After a failed merger between these two companies and an expanding genome sequencing market, which stock is a better buy?
Pet insurance provider, Trupanion, has beaten the market over the last five years and is up 100% year-to-date, but is its stock a good buy?
The healthcare industry is currently ripe for disruption, so let’s look at newly public Hims & Hers’ competitors in this lucrative space.
The betting landscape has shifted due to liberal legislation, and these three gambling stocks are set to benefit from a growing industry.
After the largest SPAC deal involving an electric vehicle company, is the soon-to-be publicly traded luxury automaker a good investment?
These three competitors could provide both investors and consumers with an alternative to Tattooed Chef in the plant-based space.
The gene-editing solution is in its infancy, and with a vast market opportunity, CRISPR Therapeutics is the stock I am buying today.
Following some massive volatility, is the innovative and sometimes controversial Lemonade a good investment?
This plant-based meat producer is the only pure-play on the market and posted record revenue in the last quarter. But how does Beyond Meat make money?
This space tourism business has a reported $80 million in deposits from over 600 wealthy customers, but what else?